Scenario.press - libera espressione Scenario.press - libera espressione
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Marketplace
  • Financement
  • Offres
  • Emplois
  • Courses
  • Film
  • Développeurs
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • marketstatistics Ajouter une nouvelle offre d'emploi Autre
    2025-08-26 07:26:54 -
    Competitive Landscape of the Immunotherapy Drugs Market (2025–2030)
    The global immunotherapy drugs market size was estimated at USD 257.6 billion in 2024 and is projected to reach USD 486.36 billion by 2030, growing at a CAGR of 11.2% from 2025 to 2030. This robust market growth is primarily fueled by the increasing prevalence of chronic diseases worldwide, which continues to create strong demand for advanced treatment options. According to data from...
    0 Commentaires 0 Parts 51 Vue
    Connectez-vous pour aimer, partager et commenter!
  • monique213 Ajouter une nouvelle offre d'emploi Health
    2025-07-14 08:55:03 -
    Organ Transplant Immunosuppressant Drugs Market Shows Strong Pipeline of Immunotherapy Drugs
    The global organ transplant immunosuppressant drugs market is projected to grow from US$ 5.6 billion in 2024 to US$ 9.0 billion by 2034, at a CAGR of 4.9%. A key reason for this growth is the rising number of organ transplant procedures. According to the World Health Organization (WHO), organ transplants are increasing every year due to a growing number of patients with end stage organ failure....
    0 Commentaires 0 Parts 650 Vue
    Connectez-vous pour aimer, partager et commenter!
© 2025 Scenario.press - libera espressione French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About us Terms & Conditions Confidentialité Business Model Dons Contactez nous Annuaire